SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    C. Downey, F. Daly, K.M. O’Boyle, An in vitro approach to assessing a potential drug interaction between MDMA (ecstasy) and caffeine, Toxicology in Vitro, 2014, 28, 2, 231

    CrossRef

  2. 2
    Christopher M. Gibson, Patrick W. Fowler, Aromaticity of caffeine, xanthine and the dimethyl xanthines, Tetrahedron Letters, 2014, 55, 13, 2078

    CrossRef

  3. 3
    Pravin Popatrao Kale, Veeranjaneyulu Addepalli, Augmentation of antidepressant effects of duloxetine and bupropion by caffeine in mice, Pharmacology Biochemistry and Behavior, 2014, 124, 238

    CrossRef

  4. 4
    Jack E. James, Caffeine and cognitive performance: Persistent methodological challenges in caffeine research, Pharmacology Biochemistry and Behavior, 2014, 124, 117

    CrossRef

  5. 5
    Marlon R. Leite, Marcel Henrique Marcondes Sari, Mayara L. de Freitas, Lia P. Oliveira, Laíza Dalmolin, Ricardo Brandão, Gilson Zeni, Caffeine and diphenyl diselenide improve long-term memory impaired in middle-aged rats, Experimental Gerontology, 2014, 53, 67

    CrossRef

  6. 6
    Sylvain Dubroqua, Samuel R. L. Low, Benjamin K. Yee, Philipp Singer, Caffeine impairs the acquisition and retention, but not the consolidation of Pavlovian conditioned freezing in mice, Psychopharmacology, 2014,

    CrossRef

  7. 7
    Guan-Yu Lu, Shih-Ming Huang, Shu-Ting Liu, Pei-Yao Liu, Wei-Yuan Chou, Wei-Shiang Lin, Caffeine induces tumor cytotoxicity via the regulation of alternative splicing in subsets of cancer-associated genes, The International Journal of Biochemistry & Cell Biology, 2014, 47, 83

    CrossRef

  8. 8
    A.P. Ardais, M.F. Borges, A.S. Rocha, C. Sallaberry, R.A. Cunha, L.O. Porciúncula, Caffeine triggers behavioral and neurochemical alterations in adolescent rats, Neuroscience, 2014, 270, 27

    CrossRef

  9. 9
    Esther Lopez-Garcia, Pilar Guallar-Castillon, Luz Leon-Muñoz, Auxiliadora Graciani, Fernando Rodriguez-Artalejo, Coffee consumption and health-related quality of life, Clinical Nutrition, 2014, 33, 1, 143

    CrossRef

  10. 10
    Michel Lucas, Eilis J. O’Reilly, An Pan, Fariba Mirzaei, Walter C. Willett, Olivia I. Okereke, Alberto Ascherio, Coffee, caffeine, and risk of completed suicide: Results from three prospective cohorts of American adults, The World Journal of Biological Psychiatry, 2014, 15, 5, 377

    CrossRef

  11. 11
    Michael E. Rybak, Ching-I Pao, Christine M. Pfeiffer, Determination of urine caffeine and its metabolites by use of high-performance liquid chromatography-tandem mass spectrometry: estimating dietary caffeine exposure and metabolic phenotyping in population studies, Analytical and Bioanalytical Chemistry, 2014, 406, 3, 771

    CrossRef

  12. 12
    Laura López-Cruz, Marta Pardo, John D. Salamone, Mercè Correa, Differences between the nonselective adenosine receptor antagonists caffeine and theophylline in motor and mood effects: Studies using medium to high doses in animal models, Behavioural Brain Research, 2014, 270, 213

    CrossRef

  13. 13
    Pravin Popatrao Kale, Veeranjaneyulu Addepalli, Enhancement of Anxiolytic Effect of Duloxetine or Bupropion by Caffeine in Mice, Journal of Caffeine Research, 2014, 140716083727007

    CrossRef

  14. 14
    Ngoc Minh Pham, Akiko Nanri, Kayo Kurotani, Keisuke Kuwahara, Ayami Kume, Masao Sato, Hitomi Hayabuchi, Tetsuya Mizoue, Green tea and coffee consumption is inversely associated with depressive symptoms in a Japanese working population, Public Health Nutrition, 2014, 17, 03, 625

    CrossRef

  15. 15
    Petar M. Nikić, Branislav R. Andrić, Biljana B. Stojimirović, Jasna Trbojevic-Stanković, Zoran Bukumirić, Habitual Coffee Consumption Enhances Attention and Vigilance in Hemodialysis Patients, BioMed Research International, 2014, 2014, 1

    CrossRef

  16. 16
    Sylvain Dubroqua, Benjamin K. Yee, Philipp Singer, Sensorimotor gating is disrupted by acute but not chronic systemic exposure to caffeine in mice, Psychopharmacology, 2014,

    CrossRef

  17. 17
    Juan Carlos Ledesma, Miguel Angel Escrig, Raúl Pastor, Carlos M.G. Aragon, The MAO-A inhibitor clorgyline reduces ethanol-induced locomotion and its volitional intake in mice, Pharmacology Biochemistry and Behavior, 2014, 116, 30

    CrossRef

  18. 18
    Marla Rivera-Oliver, Manuel Díaz-Ríos, Using caffeine and other adenosine receptor antagonists and agonists as therapeutic tools against neurodegenerative diseases: A review, Life Sciences, 2014, 101, 1-2, 1

    CrossRef

  19. 19
    Koji Yamada, Minoru Kobayashi, Tomoyuki Kanda, Adenosine Receptors in Neurology and Psychiatry, 2014,

    CrossRef

  20. 20
    Jiang-Fan Chen, Adenosine Receptors in Neurology and Psychiatry, 2014,

    CrossRef

  21. 21
    Muaz Belviranlı, Nilsel Okudan, Antioxidants in Sport Nutrition, 2014,

    CrossRef

  22. 22
    Darsi N. Pitchon, Michelle Zook, Dennis E. Rhoads, A Pattern of Adolescent Caffeine Consumption that Reduces Alcohol Withdrawal Severity, Journal of Caffeine Research, 2013, 3, 3, 131

    CrossRef

  23. 23
    C. G. Silva, C. Metin, W. Fazeli, N. J. Machado, S. Darmopil, P.-S. Launay, A. Ghestem, M.-P. Nesa, E. Bassot, E. Szabo, Y. Baqi, C. E. Muller, A. R. Tome, A. Ivanov, D. Isbrandt, Y. Zilberter, R. A. Cunha, M. Esclapez, C. Bernard, Adenosine Receptor Antagonists Including Caffeine Alter Fetal Brain Development in Mice, Science Translational Medicine, 2013, 5, 197, 197ra104

    CrossRef

  24. 24
    Nélio Gonçalves, Ana T. Simões, Rodrigo A. Cunha, Luís Pereira Almeida, Caffeine and adenosine A2A receptor inactivation decrease striatal neuropathology in a lentiviral-based model of Machado–Joseph disease, Annals of Neurology, 2013, 73, 5
  25. 25
    Vasco C. Sousa, Joaquim A. Ribeiro, Ana M. Sebastião, Caffeine and Adenosine Receptor Modulation of Cannabinoid Influence Upon Cognitive Function, Journal of Caffeine Research, 2013, 3, 2, 85

    CrossRef

  26. 26
    Suzanne J. L. Einöther, Timo Giesbrecht, Caffeine as an attention enhancer: reviewing existing assumptions, Psychopharmacology, 2013, 225, 2, 251

    CrossRef

  27. 27
    Miguel M. Acuña-Lizama, José L. Bata-García, Fernando J. Alvarez-Cervera, José L. Góngora-Alfaro, Caffeine has greater potency and efficacy than theophylline to reverse the motor impairment caused by chronic but not acute interruption of striatal dopaminergic transmission in rats, Neuropharmacology, 2013, 70, 51

    CrossRef

  28. 28
    Pablo Pandolfo, Nuno J. Machado, Attila Köfalvi, Reinaldo N. Takahashi, Rodrigo A. Cunha, Caffeine regulates frontocorticostriatal dopamine transporter density and improves attention and cognitive deficits in an animal model of attention deficit hyperactivity disorder, European Neuropsychopharmacology, 2013, 23, 4, 317

    CrossRef

  29. 29
    Steven E. Meredith, Laura M. Juliano, John R. Hughes, Roland R. Griffiths, Caffeine Use Disorder: A Comprehensive Review and Research Agenda, Journal of Caffeine Research, 2013, 3, 3, 114

    CrossRef

  30. 30
    Tina L. Skinner, David G. Jenkins, Dennis R. Taaffe, Michael D. Leveritt, Jeff S. Coombes, Coinciding exercise with peak serum caffeine does not improve cycling performance, Journal of Science and Medicine in Sport, 2013, 16, 1, 54

    CrossRef

  31. 31
    Lucia Frau, Nicola Simola, Micaela Morelli, Contribution of Caffeine to the Psychostimulant, Neuroinflammatory and Neurotoxic Effects of Amphetamine-Related Drugs, Journal of Caffeine Research, 2013, 3, 2, 79

    CrossRef

  32. 32
    M. Pardo, L. López-Cruz, O. Valverde, C. Ledent, Y. Baqi, C.E. Müller, J.D. Salamone, M. Correa, Effect of subtype-selective adenosine receptor antagonists on basal or haloperidol-regulated striatal function: Studies of exploratory locomotion and c-Fos immunoreactivity in outbred and A2AR KO mice, Behavioural Brain Research, 2013, 247, 217

    CrossRef

  33. 33
    Paola Superchi, Claudio Mazzoni, Paola Zanardelli, Chiara Piancastelli, Ernesto Mario Zambini, Valentino Beretti, Alberto Sabbioni, Effects of oral caffeine administration to sows with induced parturition on hypoxia in piglets, Livestock Science, 2013, 157, 1, 372

    CrossRef

  34. 34
    Rafael A Casuso, Antonio Martínez-Amat, Emilio J Martínez-López, Daniel Camiletti-Moirón, Jesus M Porres, Pilar Aranda, Ergogenic effects of quercetin supplementation in trained rats, Journal of the International Society of Sports Nutrition, 2013, 10, 1, 3

    CrossRef

  35. 35
    P Garção, E C Szabó, S Wopereis, A A Castro, Â R Tomé, R D Prediger, R A Cunha, P Agostinho, A Köfalvi, Functional interaction between pre-synaptic α6β2-containing nicotinic and adenosine A2A receptors in the control of dopamine release in the rat striatum, British Journal of Pharmacology, 2013, 169, 7
  36. 36
    Eduard Gracia, Estefania Moreno, Antoni Cortés, Carme Lluís, Josefa Mallol, Peter J. McCormick, Enric I. Canela, Vicent Casadó, Homodimerization of adenosine A1 receptors in brain cortex explains the biphasic effects of caffeine, Neuropharmacology, 2013, 71, 56

    CrossRef

  37. 37
    Martin Dresler, Anders Sandberg, Kathrin Ohla, Christoph Bublitz, Carlos Trenado, Aleksandra Mroczko-Wąsowicz, Simone Kühn, Dimitris Repantis, Non-pharmacological cognitive enhancement, Neuropharmacology, 2013, 64, 529

    CrossRef

  38. 38
    Sergi Ferré, Marco Orrú, Xavier Guitart, Paraxanthine: Connecting Caffeine to Nitric Oxide Neurotransmission, Journal of Caffeine Research, 2013, 3, 2, 72

    CrossRef

  39. 39
    Matthew J. Baggott, Emma Childs, Amy B. Hart, Eveline de Bruin, Abraham A. Palmer, Joy E. Wilkinson, Harriet de Wit, Psychopharmacology of theobromine in healthy volunteers, Psychopharmacology, 2013, 228, 1, 109

    CrossRef

  40. 40
    Marco Orrú, Xavier Guitart, Marzena Karcz-Kubicha, Marcello Solinas, Zuzana Justinova, Sandeep Kumar Barodia, Janaina Zanoveli, Antoni Cortes, Carme Lluis, Vicent Casado, F. Gerard Moeller, Sergi Ferré, Psychostimulant pharmacological profile of paraxanthine, the main metabolite of caffeine in humans, Neuropharmacology, 2013, 67, 476

    CrossRef

  41. 41
    Elissa B. Klaassen, Renate H.M. de Groot, Elisabeth A.T. Evers, Jan Snel, Enno C.I. Veerman, Antoon J.M. Ligtenberg, Jelle Jolles, Dick J. Veltman, The effect of caffeine on working memory load-related brain activation in middle-aged males, Neuropharmacology, 2013, 64, 160

    CrossRef

  42. 42
    Lisiane O. Porciúncula, Cássia Sallaberry, Sabrina Mioranzza, Paulo Henrique S. Botton, Denis B. Rosemberg, The Janus face of caffeine, Neurochemistry International, 2013, 63, 6, 594

    CrossRef

  43. 43
    B. Boutrel, G.F. Koob, Encyclopedia of Sleep, 2013,

    CrossRef

  44. 44
    D.P. Evatt, R.R. Griffiths, Encyclopedia of Human Nutrition, 2013,

    CrossRef

  45. 45
    Suzanne J.L. Einöther, Timo Giesbrecht, Charlotte M. Walden, Leo van Buren, Pieter C. van der Pijl, Eveline A. de Bruin, Tea in Health and Disease Prevention, 2013,

    CrossRef

  46. 46
    M. Pardo, L. Lopez-Cruz, O. Valverde, C. Ledent, Y. Baqi, C.E. Müller, J.D. Salamone, M. Correa, Adenosine A2A receptor antagonism and genetic deletion attenuate the effects of dopamine D2 antagonism on effort-based decision making in mice, Neuropharmacology, 2012, 62, 5-6, 2068

    CrossRef

  47. 47
    Fernanda Gumilar, Mariela Agotegaray, Cristina Bras, Norberto A. Gandini, Alejandra Minetti, Oscar Quinzani, Anti-nociceptive activity and toxicity evaluation of Cu(II)-fenoprofenate complexes in mice, European Journal of Pharmacology, 2012, 675, 1-3, 32

    CrossRef

  48. 48
    Margaret C. Wardle, Michael T. Treadway, Harriet de Wit, Caffeine increases psychomotor performance on the effort expenditure for rewards task, Pharmacology Biochemistry and Behavior, 2012, 102, 4, 526

    CrossRef

  49. 49
    Laura M. Juliano, Edward D. Huntley, Paul T. Harrell, Ashley T. Westerman, Development of the Caffeine Withdrawal Symptom Questionnaire: Caffeine withdrawal symptoms cluster into 7 factors, Drug and Alcohol Dependence, 2012, 124, 3, 229

    CrossRef

  50. 50
    Hsien-yang Lee, Junko Nakayama, Ying Xu, Xueliang Fan, Maha Karouani, Yiguo Shen, Emmanuel N. Pothos, Ellen J. Hess, Ying-Hui Fu, Robert H. Edwards, Louis J. Ptácek, Dopamine dysregulation in a mouse model of paroxysmal nonkinesigenic dyskinesia, Journal of Clinical Investigation, 2012, 122, 2, 507

    CrossRef

  51. 51
    Allison A. Feduccia, Yuanyuan Wang, Jeffrey A. Simms, Henry Y. Yi, Rui Li, Leonard Bjeldanes, Chuangxing Ye, Selena E. Bartlett, Locomotor activation by theacrine, a purine alkaloid structurally similar to caffeine: Involvement of adenosine and dopamine receptors, Pharmacology Biochemistry and Behavior, 2012, 102, 2, 241

    CrossRef

  52. 52
    John Seibyl, David Russell, Danna Jennings, Kenneth Marek, Neuroimaging Over the Course of Parkinson's Disease: From Early Detection of the At-Risk Patient to Improving Pharmacotherapy of Later-Stage Disease, Seminars in Nuclear Medicine, 2012, 42, 6, 406

    CrossRef

  53. 53
    Ana Diukova, Jennifer Ware, Jessica E. Smith, C. John Evans, Kevin Murphy, Peter J. Rogers, Richard G. Wise, Separating neural and vascular effects of caffeine using simultaneous EEG–FMRI: Differential effects of caffeine on cognitive and sensorimotor brain responses, NeuroImage, 2012, 62, 1, 239

    CrossRef

  54. 54
    Chris Alford, Jennifer Hamilton-Morris, Joris C. Verster, The effects of energy drink in combination with alcohol on performance and subjective awareness, Psychopharmacology, 2012, 222, 3, 519

    CrossRef

  55. 55
    Marilyn C. Cornelis, Recent Advances in Nutrigenetics and Nutrigenomics, 2012,

    CrossRef

  56. 56
    Dennis E. Rhoads, April L. Huggler, Lucas J. Rhoads, Acute and adaptive motor responses to caffeine in adolescent and adult rats, Pharmacology Biochemistry and Behavior, 2011, 99, 1, 81

    CrossRef

  57. 57
    Catarina V. Gomes, Manuella P. Kaster, Angelo R. Tomé, Paula M. Agostinho, Rodrigo A. Cunha, Adenosine receptors and brain diseases: Neuroprotection and neurodegeneration, Biochimica et Biophysica Acta (BBA) - Biomembranes, 2011, 1808, 5, 1380

    CrossRef

  58. 58
    Stacey C. Sigmon, Roland R. Griffiths, Caffeine choice prospectively predicts positive subjective effects of caffeine and d-amphetamine, Drug and Alcohol Dependence, 2011, 118, 2-3, 341

    CrossRef

  59. 59
    Gabor Perlaki, Gergely Orsi, Norbert Kovacs, Attila Schwarcz, Zilia Pap, Zsuzsanna Kalmar, Eniko Plozer, Arpad Csatho, Robert Gabriel, Samuel Komoly, Imre Janszky, József Janszky, Coffee consumption may influence hippocampal volume in young women, Brain Imaging and Behavior, 2011, 5, 4, 274

    CrossRef

  60. 60
    Marcelo T. Marin, Roberta Zancheta, Ana H. Paro, Ana P.M. Possi, Fábio C. Cruz, Cleopatra S. Planeta, Comparison of caffeine-induced locomotor activity between adolescent and adult rats, European Journal of Pharmacology, 2011, 660, 2-3, 363

    CrossRef

  61. 61
    Diogo R. Lara, Eduardo Antoniolli, Julia Frozi, Ricardo Schneider, Gustavo L. Ottoni, Distinct Personality Traits Associated with Intake of Coffee, Tea, and Cola Drinks and Smoking, Journal of Caffeine Research, 2011, 1, 2, 101

    CrossRef

  62. 62
    Catherine L.W. Striley, Roland R. Griffiths, Linda B. Cottler, Evaluating Dependence Criteria for Caffeine, Journal of Caffeine Research, 2011, 1, 4, 219

    CrossRef

  63. 63
    Christian J Cook, Blair T Crewther, Liam P Kilduff, Scott Drawer, Chris M Gaviglio, Skill execution and sleep deprivation: effects of acute caffeine or creatine supplementation - a randomized placebo-controlled trial, Journal of the International Society of Sports Nutrition, 2011, 8, 1, 2

    CrossRef

  64. 64
    Ibrahim A. Alhaider, Abdulaziz M. Aleisa, Trinh T. Tran, Karim A. Alkadhi, Sleep deprivation prevents stimulation-induced increases of levels of P-CREB and BDNF: Protection by caffeine, Molecular and Cellular Neuroscience, 2011, 46, 4, 742

    CrossRef

  65. 65
    Patrick A. Randall, Eric J. Nunes, Simone L. Janniere, Colin M. Stopper, Andrew M. Farrar, Thomas N. Sager, Younis Baqi, Jörg Hockemeyer, Christa E. Müller, John D. Salamone, Stimulant effects of adenosine antagonists on operant behavior: differential actions of selective A2A and A1 antagonists, Psychopharmacology, 2011, 216, 2, 173

    CrossRef

  66. 66
    Kezhi Liu, Xuemei Liang, Weihong Kuang, Tea consumption maybe an effective active treatment for adult attention deficit hyperactivity disorder (ADHD), Medical Hypotheses, 2011, 76, 4, 461

    CrossRef

  67. 67
    Jakov Gather, The Evaluation of Psychopharmacological Enhancers Beyond a Normative “Natural”–“Artificial” Dichotomy, Medicine Studies, 2011, 3, 1, 19

    CrossRef

  68. 68
    Caroline Mahoney, Tad Brunyé, Grace Giles, Diet, Brain, Behavior, 2011,

    CrossRef

  69. 69
    S. Cechova, A.M. Elsobky, B.J. Venton, A1 receptors self-regulate adenosine release in the striatum: evidence of autoreceptor characteristics, Neuroscience, 2010, 171, 4, 1006

    CrossRef

  70. 70
    Jessica E. Sturgess, Ryan A. Ting-A-Kee, Dominik Podbielski, Laurie H. L. Sellings, Jiang-Fan Chen, Derek Van Der Kooy, Adenosine A1 and A2A receptors are not upstream of caffeine’s dopamine D2 receptor-dependent aversive effects and dopamine-independent rewarding effects, European Journal of Neuroscience, 2010, 32, 1
  71. 71
    Melanie A. Heckman, Jorge Weil, Elvira Gonzalez De Mejia, Caffeine (1, 3, 7-trimethylxanthine) in Foods: A Comprehensive Review on Consumption, Functionality, Safety, and Regulatory Matters, Journal of Food Science, 2010, 75, 3
  72. 72
    Sean Connolly, Tami J. Kingsbury, Caffeine modulates CREB-dependent gene expression in developing cortical neurons, Biochemical and Biophysical Research Communications, 2010, 397, 2, 152

    CrossRef

  73. 73
    Paulo Henrique Botton, Marcelo S. Costa, Ana Paula Ardais, Sabrina Mioranzza, Diogo O. Souza, João Batista Teixeira da Rocha, Lisiane O. Porciúncula, Caffeine prevents disruption of memory consolidation in the inhibitory avoidance and novel object recognition tasks by scopolamine in adult mice, Behavioural Brain Research, 2010, 214, 2, 254

    CrossRef

  74. 74
    Ibrahim A. Alhaider, Abdulaziz M. Aleisa, Trinh T. Tran, Karim A. Alkadhi, Caffeine prevents sleep loss-induced deficits in long-term potentiation and related signaling molecules in the dentate gyrus, European Journal of Neuroscience, 2010, 31, 8
  75. 75
    Pravin Popatrao Kale, Veeranjaneyulu Addepalli, Pallavi Anand Bafna, Kedar S. Prabhavalkar, Caffeine-induced Augmentation of Antidepressant Therapy, Journal of Experimental & Clinical Medicine, 2010, 2, 6, 282

    CrossRef

  76. 76
    E.J. Nunes, P.A. Randall, J.L. Santerre, A.B. Given, T.N. Sager, M. Correa, J.D. Salamone, Differential effects of selective adenosine antagonists on the effort-related impairments induced by dopamine D1 and D2 antagonism, Neuroscience, 2010, 170, 1, 268

    CrossRef

  77. You have free access to this content77
    M.A. Heckman, K. Sherry, E. Gonzalez De Mejia, Energy Drinks: An Assessment of Their Market Size, Consumer Demographics, Ingredient Profile, Functionality, and Regulations in the United States, Comprehensive Reviews in Food Science and Food Safety, 2010, 9, 3
  78. 78
    Amy Yang, Abraham A. Palmer, Harriet de Wit, Genetics of caffeine consumption and responses to caffeine, Psychopharmacology, 2010, 211, 3, 245

    CrossRef

  79. 79
    J.L. Bata-García, L. Tun-Cobá, F.J. Alvarez-Cervera, J.R. Villanueva-Toledo, F.J. Heredia-López, J.L. Góngora-Alfaro, Improvement of postural adjustment steps in hemiparkinsonian rats chronically treated with caffeine is mediated by concurrent blockade of A1 and A2A adenosine receptors, Neuroscience, 2010, 166, 2, 590

    CrossRef

  80. 80
    N Vanattou-Saïfoudine, R McNamara, A Harkin, Mechanisms mediating the ability of caffeine to influence MDMA (‘Ecstasy’)-induced hyperthermia in rats, British Journal of Pharmacology, 2010, 160, 4
  81. 81
    C. Normann, J. Boldt, G. Maio, M. Berger, Möglichkeiten und Grenzen des pharmakologischen Neuroenhancements, Der Nervenarzt, 2010, 81, 1, 66

    CrossRef

  82. 82
    Jennifer Kaufling, Elisabeth Waltisperger, Romain Bourdy, Antoine Valera, Pierre Veinante, Marie-José Freund-Mercier, Michel Barrot, Pharmacological recruitment of the GABAergic tail of the ventral tegmental area by acute drug exposure, British Journal of Pharmacology, 2010, 161, 8
  83. 83
    Yida Xu, B. Jill Venton, Rapid determination of adenosine deaminase kinetics using fast-scan cyclic voltammetry, Physical Chemistry Chemical Physics, 2010, 12, 34, 10027

    CrossRef

  84. 84
    John D Salamone, Merce Correa, Andrew M Farrar, Eric J Nunes, Lyndsey E Collins, Role of dopamine–adenosine interactions in the brain circuitry regulating effort-related decision making: insights into pathological aspects of motivation, Future Neurology, 2010, 5, 3, 377

    CrossRef

  85. 85
    Olga E. González-Lugo, Fátima Ceballos-Huerta, María E. Jiménez-Capdeville, Gloria Arankowsky-Sandoval, José L. Góngora-Alfaro, Synergism of theophylline and anticholinergics to inhibit haloperidol-induced catalepsy: A potential treatment for extrapyramidal syndromes, Progress in Neuro-Psychopharmacology and Biological Psychiatry, 2010, 34, 8, 1465

    CrossRef

  86. 86
    Ewald Edink, Chimed Jansen, Rob Leurs, Iwan J.P. de Esch, The heat is on: thermodynamic analysis in fragment-based drug discovery, Drug Discovery Today: Technologies, 2010, 7, 3, e189

    CrossRef

  87. 87
    Merideth A. Addicott, Paul J. Laurienti, A comparison of the effects of caffeine following abstinence and normal caffeine use, Psychopharmacology, 2009, 207, 3, 423

    CrossRef

  88. 88
    Xiaobin Xie, Yashanad Mhaskar, Lydia A. Arbogast, Rita A. Trammell, Larry F. Hughes, Linda A. Toth, Adenosine receptor antagonists and behavioral activation in NF-κB p50 subunit knockout mice, Life Sciences, 2009, 85, 5-6, 226

    CrossRef

  89. 89
    Chih W. Hsu, C. Y. Chen, Chin-Shine Wang, Ted H. Chiu, Caffeine and a selective adenosine A2A receptor antagonist induce reward and sensitization behavior associated with increased phospho-Thr75-DARPP-32 in mice, Psychopharmacology, 2009, 204, 2, 313

    CrossRef

  90. 90
    John D. Salamone, Andrew M. Farrar, Laura Font, Vatsal Patel, Devra E. Schlar, Eric J. Nunes, Lyndsey E. Collins, Thomas N. Sager, Differential actions of adenosine A1 and A2A antagonists on the effort-related effects of dopamine D2 antagonism, Behavioural Brain Research, 2009, 201, 1, 216

    CrossRef

  91. 91
    Zuzana Justinova, Sergi Ferré, Chanel Barnes, Carrie E. Wertheim, Lara A. Pappas, Steven R. Goldberg, Bernard Le Foll, Effects of chronic caffeine exposure on adenosinergic modulation of the discriminative-stimulus effects of nicotine, methamphetamine, and cocaine in rats, Psychopharmacology, 2009, 203, 2, 355

    CrossRef

  92. 92
    H. Förstl, Neuro-Enhancement, Der Nervenarzt, 2009, 80, 7, 840

    CrossRef

  93. 93
    Rodrigo A. Cunha, Cafeína, receptores de adenosina, memoria y enfermedad de Alzheimer, Medicina Clínica, 2008, 131, 20, 790

    CrossRef

  94. 94
    M.S. Costa, P.H. Botton, S. Mioranzza, D.O. Souza, L.O. Porciúncula, Caffeine prevents age-associated recognition memory decline and changes brain-derived neurotrophic factor and tirosine kinase receptor (TrkB) content in mice, Neuroscience, 2008, 153, 4, 1071

    CrossRef

  95. 95
    R. Andretic, Y.-C. Kim, F. S. Jones, K.-A. Han, R. J. Greenspan, Drosophila D1 dopamine receptor mediates caffeine-induced arousal, Proceedings of the National Academy of Sciences, 2008, 105, 51, 20392

    CrossRef

  96. 96
    Sergi Ferré, La cafeína en la enfermedad de Parkinson, Medicina Clínica, 2008, 131, 18, 710

    CrossRef

  97. 97
    R. Moratalla, Neurobiología de las metilxantinas, Trastornos Adictivos, 2008, 10, 3, 201

    CrossRef

  98. 98
    V.-P. Jaakola, M. T. Griffith, M. A. Hanson, V. Cherezov, E. Y. T. Chien, J. R. Lane, A. P. IJzerman, R. C. Stevens, The 2.6 Angstrom Crystal Structure of a Human A2A Adenosine Receptor Bound to an Antagonist, Science, 2008, 322, 5905, 1211

    CrossRef

  99. 99
    F. Gerard Moeller, Joy M. Schmitz, David Herin, Kimberly L. Kjome, Use of stimulants to treat cocaine and methamphetamine abuse, Current Psychiatry Reports, 2008, 10, 5, 385

    CrossRef